Analyst
MoneyVisers
Equibles does not estimate personal net worth.
Urmish Shah is recorded as Analyst at MoneyVisers. Urmish Shah has spoken on 2 earnings calls across 2 companies, most recently for Jagsonpal Pharmaceuticals Limited on October 29, 2026. Those appearances were for Jagsonpal Pharmaceuticals Limited and Modis Navnirman Limited. The companies whose calls Urmish Shah spoke on are classified in the Healthcare and Real Estate sectors.
“First one is on the degrowth in IndoorCap and Equidex in terms of brand match. Could you just give me the reason of why we are seeing a degrowth?”
“My first question is, you know, could you just help me understand which projects aided the exponential growth in terms of sales value that we have, you know, clocked 273% growth in FY27.”
MoneyVisers
Analyst
Transcript header (unverified)
Jagsonpal Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Modis Navnirman Limited
Real Estate - Development · Real Estate
Earnings Call
Jagsonpal Pharmaceuticals Limited
Earnings Call for the Quarter Ended September 30, 2026
Modis Navnirman Limited
